135 related articles for article (PubMed ID: 10389069)
1. The quantity and duration of the antimicrobial efficacy of a chlorhexidine and silversulfadiazine impregnated catheter.
Schierholz JM; Beuth J; Pulverer G
J Hosp Infect; 1999 Jun; 42(2):163-5. PubMed ID: 10389069
[No Abstract] [Full Text] [Related]
2. A meta-analysis dealing with the effectiveness of chlorhexidine and silver-sufhadiazine impregnated central venous catheters.
Haxhe JJ; D'Hoore W
J Hosp Infect; 1998 Oct; 40(2):166-8. PubMed ID: 9819700
[No Abstract] [Full Text] [Related]
3. Anti-infective external coating of central venous catheters: a randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine/silver sulfadiazine in preventing catheter colonization.
Walz JM; Avelar RL; Longtine KJ; Carter KL; Mermel LA; Heard SO;
Crit Care Med; 2010 Nov; 38(11):2095-102. PubMed ID: 20711070
[TBL] [Abstract][Full Text] [Related]
4. Measurement of ultrasonic-induced chlorhexidine liberation: correlation of the activity of chlorhexidine-silver-sulfadiazine-impregnated catheters to agar roll technique and broth culture.
Schierholz JM; Bach A; Fleck C; Beuth J; König D; Pulverer G
J Hosp Infect; 2000 Feb; 44(2):141-5. PubMed ID: 10662565
[TBL] [Abstract][Full Text] [Related]
5. A pioneer approach to preventing central venous catheter infections.
Carlson RW; Patterson T
Crit Care Med; 2010 Nov; 38(11):2255-7. PubMed ID: 20959753
[No Abstract] [Full Text] [Related]
6. Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit.
Osma S; Kahveci SF; Kaya FN; Akalin H; Ozakin C; Yilmaz E; Kutlay O
J Hosp Infect; 2006 Feb; 62(2):156-62. PubMed ID: 16307824
[TBL] [Abstract][Full Text] [Related]
7. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial.
Logghe C; Van Ossel C; D'Hoore W; Ezzedine H; Wauters G; Haxhe JJ
J Hosp Infect; 1997 Oct; 37(2):145-56. PubMed ID: 9364263
[TBL] [Abstract][Full Text] [Related]
9. [Anaphylactic shock associated with a central venous catheter impregnated with chlorhexidine and silver sulfadiazine].
Terazawa E; Nagase K; Masue T; Niwa Y; Fukao I; Shimonaka H; Yokoi T; Kondoh N; Dohi S
Masui; 1998 May; 47(5):556-61. PubMed ID: 9621664
[TBL] [Abstract][Full Text] [Related]
10. The relationship between methodological trial quality and the effects of impregnated central venous catheters.
Geffers C; Zuschneid I; Eckmanns T; Rüden H; Gastmeier P
Intensive Care Med; 2003 Mar; 29(3):403-9. PubMed ID: 12577150
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of an antiseptic-impregnated central venous catheter in the ICU.
Frank U; Chojnacki T; Dettenkofer M; Daschner FD
Intensive Care Med; 2003 Jan; 29(1):139. PubMed ID: 12528036
[No Abstract] [Full Text] [Related]
12. Antimicrobial-impregnated central venous catheters.
Yasukawa T; Fujita Y; Sari A
N Engl J Med; 1999 Jun; 340(22):1762. PubMed ID: 10357633
[No Abstract] [Full Text] [Related]
13. Antimicrobial-impregnated central venous catheters.
Paterson DL
N Engl J Med; 1999 Jun; 340(22):1761; author reply 1762. PubMed ID: 10357631
[No Abstract] [Full Text] [Related]
14. Antimicrobial-impregnated central venous catheters.
Maury E; Offenstadt G
N Engl J Med; 1999 Jun; 340(22):1761-2; author reply 1762. PubMed ID: 10357632
[No Abstract] [Full Text] [Related]
15. Susceptibility of coagulase-negative staphylococcal nosocomial bloodstream isolates to the chlorhexidine/silver sulfadiazine-impregnated central venous catheter.
Rosato AE; Tallent SM; Edmond MB; Bearman GM
Am J Infect Control; 2004 Dec; 32(8):486-8. PubMed ID: 15573055
[No Abstract] [Full Text] [Related]
16. Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised study.
Camargo LF; Marra AR; Büchele GL; Sogayar AM; Cal RG; de Sousa JM; Silva E; Knobel E; Edmond MB
J Hosp Infect; 2009 Jul; 72(3):227-33. PubMed ID: 19443078
[TBL] [Abstract][Full Text] [Related]
17. Central venous catheterization: a prospective, randomized, double-blind study.
Mer M; Duse AG; Galpin JS; Richards GA
Clin Appl Thromb Hemost; 2009 Feb; 15(1):19-26. PubMed ID: 18593746
[TBL] [Abstract][Full Text] [Related]
18. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial chlorhexidine/silver sulfadiazine-coated central venous catheters versus those uncoated in patients undergoing allogeneic stem cell transplantation.
Vokurka S; Kabatova-Maxova K; Skardova J; Bystricka E
Support Care Cancer; 2009 Feb; 17(2):145-51. PubMed ID: 18449570
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcus aureus bacteraemia associated with peripherally inserted central catheters: the role of chlorhexidine gluconate-impregnated sponge dressings.
Loftus MJ; Florescu CJ; Stuart RL
Med J Aust; 2014 Apr; 200(6):317-8. PubMed ID: 24702084
[No Abstract] [Full Text] [Related]
[Next] [New Search]
